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Abstract
Bio-production of fuels and chemicals from lignocellulosic C5 sugars usually requires the use of the pentose phosphate
pathway (PPP) to produce pyruvate. Unfortunately, the oxidation of pyruvate to acetyl-coenzyme A results in the loss of 33%
of the carbon as CO2, to the detriment of sustainability and process economics. To improve atom efficiency, we engineered
Escherichia coli to utilize D-xylose constitutively using the Weimberg pathway, to allow direct production of 2-oxoglutarate
without CO2 loss. After confirming enzyme expression in vitro, the pathway expression was optimized in vivo using a
combinatorial approach, by screening a range of constitutive promoters whilst systematically varying the gene order. A PPP-
deficient (DxylAB), 2-oxoglutarate auxotroph (Dicd) was used as the host strain, so that growth on D-xylose depended on the
expression of the Weimberg pathway, and variants expressing Caulobacter crescentus xylXAB could be selected on minimal
agar plates. The strains were isolated and high-throughput measurement of the growth rates on D-xylose was used to
identify the fastest growing variant. This strain contained the pL promoter, with C. crescentus xylA at the first position in the
synthetic operon, and grew at 42% of the rate on D-xylose compared to wild-type E. coli using the PPP. Remarkably, the
biomass yield was improved by 53.5% compared with the wild-type upon restoration of icd activity. Therefore, the strain
grows efficiently and constitutively on D-xylose, and offers great potential for use as a new host strain to engineer carbon-
efficient production of fuels and chemicals via the Weimberg pathway.
INTRODUCTION
Second-generation manufacturing of bio-based chemicals
depends on the utilization of lignocellulosic wastes from
food production and agriculture, to avoid any competition
with human food supplies, a crucial requirement in a world
where there is already insufficient food to feed a growing
human population [1]. C5 sugars (e.g. D-xylose) account for
a large proportion of all monosaccharides entrapped within
lignocellulosic wastes [2, 3]. Therefore, efficient utilization
of C5 sugars is a critical target for sustainable bio-produc-
tion of chemicals and fuels [4–7].
In the conventional microbial strains used as cell factories
(e.g. yeast and Escherichia coli), D-xylose is fermented via
the pentose phosphate pathway (PPP). However, the engi-
neered metabolic pathways used for chemical production
often require the production of tricarboxylic acid (TCA)
cycle intermediates, which are then elaborated to the final
chemical products. The PPP results in the formation of
pyruvate, which is then oxidized to acetyl-coenzyme A (ace-
tyl-CoA), the substrate for the TCA cycle. Unfortunately,
the production of acetyl-CoA also produces CO2, thus wast-
ing 33% of the substrate carbon (Fig. 1). Since atom effi-
ciency is a key driver for the sustainability and economic
viability of the chemical industry [8], we engineered an
E. coli strain that can grow on lignocellulosic D-xylose con-
stitutively via the Weimberg pathway.
The Weimberg pathway [9] allows the direct oxidation of
D-xylose to 2-oxoglutarate, allowing direct conversion of the
C5 skeleton to a C5 TCA cycle intermediate, without CO2
evolution (Fig. 1). The pathway is initiated by the conversion
of D-xylose to D-xylonolactone, catalyzed by xylose dehydro-
genase (XDH), followed by xylonolactonase (XL)-catalyzed
hydrolysis and ring opening to form D-xylonate, and dehy-
dration to 2-keto-3-deoxy-D-xylonate (D-KDX), catalyzed by
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xylonate dehydratase (XD). D-KDX dehydratase (KdxD) then
catalyzes the formation of 2,5-dioxopentanoate, which is oxi-
dized to 2-oxoglutarate by 2,5-dioxopentanoate dehydroge-
nase (DPDH).
The Weimberg pathway has already attracted significant
attention as a means to develop carbon-efficient engineered
metabolic pathways for bio-based production of chemicals.
For example, upstream enzymes from the Weimberg path-
way have been coupled with a decarboxylase from Pseudo-
monas putida or Lactobacillus lactis and native E. coli
alcohol dehydrogenases or aldehyde dehydrogenases to pro-
duce D-1,2,4-butanetriol, D-1,4-butanediol and 3,4-dihy-
droxybutyric acid from D-xylose [10–16]. The complete
pathway has also been used to produce glutaric acid and
mesaconic acid using E. coli as the host strains, or to
improve Corynebacterium glutamicum D-xylose utilization
[17–21]. However, these systems relied on inducible expres-
sion, using an expensive inducer (IPTG), which increases
the process costs. Furthermore, the engineered E. coli strains
were dependent on glucose for growth in minimal media
[17, 19], so that the benefit of using D-xylose to manufacture
the chemicals is offset by the use of food-grade glucose to
produce the E. coli biocatalyst. The engineered C. glutami-
cum strains could grow on D-xylose alone, but the growth
rates were only a fraction of those achieved by the progeni-
tor strains using the PPP [18, 20]. Therefore, we developed
an E. coli strain that is able to grow efficiently and constitu-
tively using the Weimberg pathway to oxidize D-xylose as
the sole carbon and energy source. This new strain offers
great potential as a novel host for future metabolic
Fig. 1. D-xylose assimilation pathways. The figure shows D-xylose assimilation via the pentose phosphate pathway, the Weimberg
pathway and the Dahms pathway. The reactions of the pentose phosphate pathway and of the Dahms pathway are native in E. coli. The
five reactions of the Weimberg pathway (blue box) require enzymes from Caulobacter crescentus, as indicated. The hydrolysis of xylo-
nolactone can also occur spontaneously [30] and, in E. coli, the dehydration of xylonate is also catalyzed by the native yjhG and yagF
gene activity [26–29].
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engineering to manufacture bio-based chemicals from ligno-
cellulosic sugars.
METHODS
Materials and growth media
The enzymes for gene cloning, plasmid purification kits
and SDS-PAGE materials were purchased from Fermentas,
Qiagen and Bio-Rad, respectively. 2-Keto-3-deoxy-D-xylo-
nate (D-KDX) was synthesized using an established proce-
dure [22], except for the preparation of the phosphonate
silyl ester (Fig. S1, available in the online version of this
article). All the other chemicals were purchased from
Sigma-Aldrich.
The E. coli strains were cultured at 37

C with shaking at
200 r.p.m. (unless specified otherwise) in either LB or ML
medium. The ML medium contained (per L) (NH4)SO4 (2 g),
K2HPO4 (14.6 g), NaH2PO4.2H2O (3.6 g) and NH4Cl (0.24 g)
added from a 5 concentrated stock solution; MgSO4
(0.24 g) added from a 100stock solution; and CaCl2.2H2O
(1mg), FeCl3 (20.06mg), ZnSO4.7H2O (0.36mg), CuSO4
.5H2O (0.32mg), MnSO4.H2O (0.30mg), CoCl.6H2O
(0.36mg) and Na2EDTA.2H2O (44.6mg) added from a 500
stock solution. D-Xylose or D-glucose (10 g l 1) were also
added from stock solutions to produce ML-X and ML-G,
respectively, and dH2O was used to adjust the volume to 1 l.
Agar (15 g l 1) was added as required. All of the solutions
were autoclaved before utilization. When required, kanamy-
cin, carbenicillin and chloramphenicol were added from fil-
ter-sterilized stock solutions to final concentrations of 50, 50
and 34mg l 1 to produce ML-XKm, ML-XCb or ML-XCm,
or LB-Km, LB-Cb or LB-Cm, respectively. The stock cultures
were prepared by mixing cultures growing exponentially in
LB (0.85ml) with sterile 80% glycerol solution (0.15ml) and
then stored at 80

C.
Preparation of E. coli strains
Caulobacter crescentus xylX, xylA, xylB, xylC and xylD (xylXCc
xylACc, xylBCc, xylCCc, xylDCc; Genbank [23] gene ID 7329906,
7329905, 7329904, 7329903 and 7329902, respectively) were
optimized for expression in E. coli (Fig. S2), synthesized by
Biomatik and inserted into pET-20b(+) using the NdeI and
NotI restriction sites to obtain inducible expression. E. coli
BL21(DE3) pLysS pET-20b(+)xylXCc,, pET-20b(+)xylACc,
pET-20b(+)xylBCc, pET-20b(+)xylCCc and pET-20b(+)xylDCc
were prepared by transforming E. coli BL21(DE3) pLysS by
heat shock. Transformants were selected on LB-Cb-Cm agar
supplemented with glucose. E. coli BL21(DE3) pLysS was also
transformed with empty pET-20b(+).
The host strains for constitutive expression, E. coli BW25113
Dicd DxylAB :: CmR and E. coli BW25113 DxylAB :: CmR, were
constructed [24] by deleting icd in the former strain, and then
deleting E. coli xylA and xylB (xylAEc and xylBEc) in a single
step, since the two genes are adjacent on the chromosome. A
chloramphenicol resistance cassette was left at the DxylAB
site. The primers used for icd deletion were 5¢-ATATG
CAACGTGGTGGCAGACGAGCAAACCAGTAGCGCTCG
AAGGAGAGGGTGTAGGCTGGAGCTGCTTC-3¢ and 5¢-
AAAACAACGGGAGCGTTACGCTCCCGTTAATAAATT
TAACAAACTACGGCATGGGAATTAGCCATGGTCC-3¢.
The primers used for xylABEc deletion were 5¢-CGACAT-
CATCCATCACCCGCGGCATTACCTGATTATGGAGTT-
CAATATGGTGTAGGCTGGAGCTGCTTC-3¢ and 5¢-CCC
GGTCAGGCAGGGGATAACGTTTACGCCATTAATGGC
AGAAGATGGGAATTAGCCATGGTCC-3¢. The deletions
were confirmed by PCR [24].
E. coli BW25113 Dicd DxylAB :: CmR was transformed by
electroporation (Gene Pulser Xcell System; Bio-Rad) with
six different plasmid libraries containing combinations of
xylXCc, xylACc and xylBCc, and combinations of four differ-
ent promoters (pL, pAspC, pR and pOSMY; Fig. S3). The
plasmid backbone, pCX, contained a pMB1 origin of repli-
cation and a kanamycin resistance cassette. Libraries were
generated using Ingenza Ltd’s proprietary combinatorial
DNA assembly method (inABLE), where the required genes
and promoters are left with overhangs using Type IIS
restriction enzymes and then ligated with specific linkers.
E. coli BW25113 Dicd DxylAB :: CmR and E. coli BW25113
DxylAB :: CmR were also transformed with the pCX and
pCL empty vectors, and pCL-xylCDCc. The pCL plasmid
and pCL-xylCDCc were also prepared using inABLE and
contained a p15A origin of replication, an ampicillin resis-
tance cassette and a pL promoter. Transformants were
selected on LB-Cb or LB-Km agar, and cells from the pCX
libraries were pooled for screening by resuspending the col-
onies in LB (2ml) using a spreader, and mixing the cell sus-
pension (0.85ml) with 80% glycerol solution (0.15ml) for
storage at  80

C.
In vitro enzyme activity assays
Enzyme activity was confirmed by measuring the conver-
sion of D-xylose to 2-oxoglutarate using mixtures of the
individual cell-free extracts. E. coli BL21(DE3) pLysS pET-
20b(+)xylXCc,, pET-20b(+)xylACc, pET-20b(+)xylBCc, pET-
20b(+)xylCCc and pET-20b(+)xylDCc were plated onto
LB-Cb-Cm agar from frozen stock cultures, and single colo-
nies were inoculated into LB-Cb-Cm (20ml). After over-
night growth, these precultures were used to inoculate
LB-Cb-Cm (100ml) to an optical density (OD600) of
approximately 0.1. Enzyme expression was induced at an
OD600 of approximately 0.6, by adding IPTG (0.4mM),
decreasing the temperature as specified in the text. The cells
were collected 14–18 h after induction by centrifugation at
15 000 g for 10min, resuspended in cold 100mM Tris-HCl
buffer, pH 7.4, and lysed with a Constant Systems cell dis-
ruptor, with all procedures being performed at 4

C. Cell
debris was removed by centrifugation at 15 000 g for 15min.
Enzyme expression was checked by SDS-PAGE using a
Mini-Protean electrophoresis system and TGX precast gels
stained with QC colloidal Coomassie protein stain. Total
protein concentration was determined using the Bio-Rad
DC protein assay kit. Cell-free extracts from the E. coli
strains expressing individual C. crescentus genes encoding
for XDH, XL, XD, KdxD and DPDH were mixed together
Rossoni et al., Microbiology 2018;164:287–298
289
Downloaded from www.microbiologyresearch.org by
IP:  128.243.39.164
On: Fri, 18 May 2018 08:26:45
in the same buffer and assayed upon the addition of MgCl2,
D-xylose or D-KDX, NAD and NADP, using the concentra-
tions and conditions specified in the text. The reaction
mixtures were analysed after 6 h.
In vivo screening for a functional Weimberg
pathway
Frozen stock cultures of E. coli BW25113 Dicd DxylAB ::
CmR strains transformed with the pCX plasmid libraries
(100 µl) were washed three times by centrifugation at
15 000 g for 5min, resuspended in sterilized phosphate-buff-
ered saline (PBS; pH 7.4) (containing NaCl, 8 g l 1; KCl,
0.2 g l 1; Na2HPO4, 1.42 g l
 1; KH2PO4, 0.24 g l
 1) and
plated onto ML-XKm medium, alongside E. coli BW25113
and E. coli BW25113 Dicd DxylAB :: CmR containing pCX as
controls. After incubation, 12 single colonies from different
libraries were randomly used to inoculate a 100-well Bio-
screen plate containing ML-XKm medium (360 µl culture
volume). Growth was measured at 37

C with shaking using
a Bioscreen C (Labsystems, Helsinki, Finland), which auto-
matically measures OD600. Growth rates were calculated by
selecting data points from the exponential phase by visual
inspection of a plot of lnOD600 versus time and using linear
regression. The fastest growing strains (25) amongst all the
libraries were isolated on LB-Km agar and their growth
rates were measured as above by preculturing them in ML-
XKm (20ml) and using the precultures to inoculate well-
plate cultures at an initial OD600 of 0.1. The three strains
with the fastest growth rates were reisolated as above, and
the plasmids were extracted using a QIAprep Spin Midiprep
kit and sent to Eurofins for sequencing.
The growth rates of the isolated strains were also measured
accurately by using single colonies grown on ML-XKm agar
plates to inoculate precultures in ML-XKm medium
(20ml). After ~24 h, the cells were collected by centrifuga-
tion at 10 000 g for 20min, washed three times aseptically in
sterilized PBS and used to inoculate ML-XKm or ML-GKm
medium (100ml). The OD600 was monitored at intervals
and the growth rates were calculated as described above.
When required, samples (1ml) were also taken at intervals
to analyse the concentration of metabolites.
Analytical methods
The OD600 of cultures was determined by aseptically sam-
pling growing cultures, diluting in water to OD<0.8 and
measuring the OD at 600 nm. The dry cell weight was esti-
mated using a calibration curve of OD600 versus dry weight.
Biomass yields were calculated by dividing the total biomass
produced (g dry weight) by the total amount of D-xylose con-
sumed (g). D-Xylose and all of the metabolites were quanti-
fied by high-pressure liquid chromatography (HPLC) using
an Agilent 1200 Series HPLC system. Samples from cultures
or in vitro enzyme assays were centrifuged and filtered
(0.2 µm filters), and filtrate samples (20 µl) injected onto a
Rezex ROA-Organic Acid H+(8%) column (Phenomenex)
at 55

C using an autosampler. The mobile phase was
0.005M H2SO4 (0.5mlmin
 1). The sample components
were detected using a refractive index detector (G1362A
Detector) at 35

C and a UV detector (G1314B Variable
Wavelength Detector) at 215 nm. Data analysis was per-
formed with ChemStation software, using calibration curves
prepared using authentic standards of each compound (0.1–
50mM).
D-Xylonate and D-xylonolactone co-elute on HPLC, and,
therefore were detected and quantified using the hydroxa-
mate method described by Lien [25]. This method converts
D-xylonate to D-xylonolactone and, for this reason, the text
refers to the two compounds as D-xylonate/D-xylonolactone.
This assay was sensitive to 0.1 g l 1 D-xylonolactone.
RESULTS
In vitro demonstration of the Weimberg pathway in
E. coli
To ensure the successful engineering of the constitutive
Weimberg pathway, we confirmed that the C. crescentus
genes, xylXABCc, encoding for KdxD, DPDH and XDH,
respectively, could be expressed in E. coli in active form.
The native E. coli genes, yjhG and yagF, encode XD activity
[26–29], and D-xylonate can be formed by spontaneous
chemical hydrolysis of D-xylonolactone [30], so the expres-
sion of xylXABCc alone ought to be sufficient to obtain a
functional Weimberg pathway in E. coli.
The codon-optimized synthetic genes were inserted individ-
ually into the pET-20b(+) vector, and the resulting plasmids
were transformed into E. coli BL21(DE3) pLysS to produce
E. coli BL21(DE3) pLysS pET-20b(+)xylXCc, pET-20b(+)
xylACc and pET-20b(+)xylBCc. XDH and KdxD (encoded by
xylBCc and xylXCc, respectively) were expressed as soluble
enzymes when the cells were grown at 37

C and the tem-
perature was decreased to 30

C after induction, but DPDH
(encoded by xylACc) was expressed most efficiently when
the temperature was decreased from 37 to 18

C after induc-
tion (Fig. S5).
The activity of XDH, KdxD and DPDH was tested by mix-
ing cell-free extracts from E. coli BL21(DE3) pLysS pET-20b
(+)xylXCc, pET-20b(+)xylACc and pET-20b(+)xylBCc and
testing for the conversion of D-xylose to 2-oxoglutarate in
the presence of NAD and NADP, which are required for
XDH and DPDH activity, respectively (Fig. 2). Control
reactions without cofactors, and an extract of an isogenic
strain transformed with the empty-pET-20b(+) vector
[E. coli BL21(DE3) pLysS pET-20b(+)] consumed 28±7 and
23±1% of the D-xylose, respectively, presumably due to the
native PPP in the host strain, but no metabolic products
from the Weimberg pathway could be detected, as expected.
By contrast, D-xylose was consumed completely by the mix-
ture of cell-free extracts containing XDH, KdxD and
DPDH. However, D-xylonolactone/D-xylonate accumulated
(4.53±0.17mM from 5mM D-xylose; Fig. 2), and neither
D-KDX nor 2-oxoglutarate could be detected. This indicated
that XDH was active, and was able to convert D-xylose to
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D-xylonolactone, but that there was a bottleneck further
along the pathway.
To identify this bottleneck, D-KDX was added to the xylose-
containing reaction mixture. This resulted in the formation
of 2-oxoglutarate in addition to D-xylonolactone/D-xylonate
(Fig. 2), and, thus demonstrated that the downstream path-
way enzymes, KdxD and DPDH, were active. This suggests
that the XD activity provided by the native E. coli enzymes
encoded by yjhG and yagF was insufficient to allow oxida-
tion of D-xylonate to D-KDX in these enzyme assays in vitro,
even though these activities are known to be sufficient to
support in vivo oxidation of D-xylose [26]. Thus, we have
confirmed that the Weimberg pathway can function in
vitro, but that conversion of D-xylonate to D-KDX may be a
limiting step in the pathway, as proposed previously [18].
In vivo optimization of constitutive expression of
the Weimberg pathway for growth of E. coli on
D-xylose
The next step was to engineer a strain that could grow con-
stitutively on D-xylose using the Weimberg pathway. A
combinatorial approach was used to optimize pathway
expression, by systematically testing different constitutive
promoters and synthetic operons with the pathway genes in
different orders.
The pathway functionality was tested by employing a
growth-based screen, using an auxotrophic mutant of E. coli
BW25113 that requires 2-oxoglutarate for growth, by
knocking out the isocitrate dehydrogenase gene, icd. In
E. coli, this enzyme is essential for production of 2-oxogluta-
rate de novo. Since 2-oxoglutarate is crucial for cell growth
and viability, this made the cells dependent on the efficient
expression of the Weimberg pathway to convert D-xylose to
2-oxoglutarate. We also deleted xylAEc and xylBEc, encoding
xylose isomerase and xylulokinase, respectively, thus inacti-
vating the first two steps of the PPP (Fig. 1). Therefore, the
resulting strain, E. coli BW25113 Dicd DxylAB :: CmR, could
be used as the host to screen for an active Weimberg
pathway.
Six different combinatorial plasmid libraries were generated
using xylXCc, xylACc and xylBCc, encoding KdxD, DPDH
and XDH, respectively. These three genes alone should be
sufficient for D-xylose oxidation via the Weimberg pathway
in growing E. coli cells [26–29]. The six libraries employed
the same plasmid backbone (pCX), and contained a syn-
thetic operon with the xylXCc, xylACc and xylBCc genes in
different orders, under the control of four different known
constitutive promoters (pL, pAspC, pR and pOSMY;
Fig. S3; Table 1).
E. coli BW25113 Dicd DxylAB :: CmR was transformed with
the plasmid libraries. The variants were then screened by
plating onto ML minimal medium containing D-xylose as
sole carbon source and kanamycin (ML-XKm), and com-
pared with the control strains with empty pCX, E. coli
BW25113 pCX and E. coli BW25113 Dicd DxylAB :: CmR
pCX.
E. coli BW25113 Dicd DxylAB :: CmR pCX did not grow at
all, due to lack of the PPP and isocitrate dehydrogenase,
whereas wild-type E. coli BW25113 pCX produced colonies
after 14–16 h (Fig. S6), due to the presence of the PPP. Colo-
nies were also visible on the plates containing E. coli
BW25113 Dicd DxylAB :: CmR transformed with the plasmid
libraries after 24–48 h (Fig. S6). This demonstrated that the
expression of KdxD, DPDH and XDH allowed E. coli to
grow on D-xylose by using the Weimberg pathway, and con-
firmed that the native XD activity and the chemical
Fig. 2. In vitro characterization of the Weimberg pathway. Cell-free
extracts of E. coli BL21(DE3) pLysS pET-20b(+)xylBCc, pET-20b(+)xylXCc
and pET-20b(+)xylACc, expressing XDH, KdxD or DPDH, respectively,
were obtained individually, mixed as indicated and assayed for the for-
mation of 2-oxoglutarate from D-xylose (5mM) in reaction mixtures
(1ml in microcentrifuge tubes) containing 100mM Tris-HCl buffer, pH
7.4, MgCl2 (50mM), NAD
+ (10mM) and NADP+ (10mM) at 37

C, with
shaking at 200 r.p.m. The amount of total protein added from each
cell-free extract was 0.1mg. Where indicated, D-KDX (2mM) was also
added to the reaction mixture in addition to D-xylose. The controls con-
sisted of cell-free extract from E. coli BL21 (DE3) pLysS pET-20b(+)
and a cofactor-free control containing XDH, KdxD and DPDH. Product
concentrations were determined after 6 h. D-KDX could not be detected
in any of the reactions. Assays were performed in triplicate, and the
means and standard errors are shown.
Table 1. Summary of the design of the plasmid libraries for the
constitutive expression of xylXCc, xylACc and xylBCc
Library # Order of genes in synthetic operon Promoters
1 xylBXACc Four possible
promoters
pL
pAspC
pR
pOSMY
2 xylBAXCc
3 xylXABCc
4 xylXBACc
5 xylABXCc
6 xylAXBCc
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hydrolysis of xylonolactone were sufficient to support
growth and 2-oxoglutarate production [26].
The incubation time required to obtain visible colonies var-
ied amongst the six libraries, and the size of the colonies
varied within each library, indicating that the order of the
genes and the promoters influenced the growth efficiency.
Twelve strains from each library were selected at random,
isolated and tested for growth on D-xylose by inoculating
single colonies into a microtitre plate, and compared with
wild-type E. coli BW25113 pCX (Fig. 3). All of the variants
grew on D-xylose, although more slowly than E. coli
BW25113 pCX using the native PPP. However, the growth
rates varied significantly, both within the same library and
amongst different libraries. When xylXCc (encoding KdxD)
or xylACc (encoding DPDH) were at the first position in the
synthetic operon (libraries 3, 4, 5 and 6), there was a broad
distribution of different growth rates amongst the individual
strains, whereas all the strains grew very slowly when xylBCc
(encoding XDH) was the first gene (libraries 1 and 2).
A further round of screening was then performed, in which
the fastest growing strains amongst libraries 3, 4, 5 and 6–
25 in total – were retested for growth on D-xylose in micro-
titre plates, but this time by inoculation from precultures to
ensure that all of the cultures had the same initial OD600
(data not shown). The three variants with the highest
growth rates were isolated (two from library 5 and one from
library 6), and the plasmids extracted and sequenced. The
two variants from library 5 contained the same plasmid,
pCX-pL-xylABXCc, whilst the library 6 variant contained
pCX-pL-xylAXBCc. Therefore, the pL promoter with xylACc
at the first position in the operon provided the most benefi-
cial combination for efficient growth using the Weimberg
pathway.
The growth rates of E. coli BW25113 Dicd DxylAB :: CmR
pCX-pL-xylABXCc and E. coli BW25113 Dicd DxylAB :: Cm
R
pCX-pL-xylAXBCc were measured accurately in shake flask
cultures (Fig. S7). E. coli BW25113 Dicd DxylAB :: CmR
pCX-pL-xylAXBCc grew at a rate of 0.20±0.01 h
 1, whilst
E. coli BW25113 Dicd DxylAB :: CmR pCX-pL-xylABXCc
grew at a rate of 0.18±0.01 h 1, 42 and 38%, respectively, of
the growth rate of E. coli BW25113 pCX, which utilizes
D-xylose via the PPP (0.48±0.01 h 1). Neither of the engi-
neered strains was able to grow on glucose as sole carbon
source (Fig. S7), due to the deletion of icd, which confirms
that the Weimberg pathway is required for the production
of 2-oxoglutarate. Due to the faster growth rate, E. coli
BW25113 Dicd DxylAB :: CmR pCX-pL-xylAXBCc was
selected for further experiments
Strain optimization
Although E. coli BW25113 Dicd DxylAB :: CmR pCX-pL-
xylAXBCc was able to grow constitutively on D-xylose using
the Weimberg pathway, the growth rate was slower than
that for E. coli BW25113 pCX, which utilizes the PPP. How-
ever, the enzyme assays had indicated that spontaneous
hydrolysis of D-xylonolactone and the native E. coli XD
activity encoded by yjhG and yagF could be rate-limiting for
the complete oxidation of xylose to 2-oxoglutarate in vitro
(Fig. 2). Therefore, we tested the addition of XL and XD,
encoded by xylCCc and xylDCc, to increase the rate of D-xylo-
nate formation from D-xylonolactone [31, 32] and increase
the rate of D-KDX formation from D-xylonate [18].
Initially, we confirmed that xylCCc and xylDCc could be
expressed in E. coli. XL and XD were expressed as a soluble
proteins when E. coli BL21(DE3) pLysS pET-20b(+)xylCCc
and E. coli BL21(DE3) pLysS pET-20b(+)xylDCc, respec-
tively, were grown at 37

C and cooled to 30 and 18

C after
induction, respectively (Fig. S5). Enzyme activity was con-
firmed by demonstrating that D-xylose was fully consumed
and converted to 2-oxoglutarate in vitro, using mixtures of
cell-free extracts from E. coli BL21(DE3) pLysS pET-20b(+)
xylCCc and E. coli BL21(DE3) pLysS pET-20b(+)xylDCc,
expressing C. crescentus XL and XD, respectively, with
extracts containing XDH, KdxD and DPDH. 2-Oxogluta-
rate was not produced when only XL, XDH, KdxD and
DPDH were present (Fig. 4). Therefore, XD activity was the
limiting step of the pathway in vitro. However, the XD-con-
taining enzyme mixture only produced 0.26±0.03mM
2-oxoglutarate, and D-xylonolactone/D-xylonate accumula-
tion was still observed (4.44±0.17mM). Therefore, the con-
centration of XD was doubled and tripled, and this resulted
in increased formation of 2-oxoglutarate (0.72±0.03 and
1.24±0.05mM, respectively) and decreased accumulation of
D-xylonolactone/D-xylonate (3.53±0.05 and 2.34±0.05mM,
respectively), further confirming that XD activity is the lim-
iting step in 2-oxoglutarate formation in vitro.
We then tested the effect of expressing C. crescentus XD and
XL on the growth of E. coli on D-xylose in vivo by transform-
ing E. coli BW25113 Dicd DxylAB :: CmR pCX-pL-xylAXBCc
with an extra plasmid, pCL-xylCDCc, under the control of the
pL promoter to produce the complete Weimberg pathway
from C. crescentus. Although E. coli BW25113 Dicd DxylAB ::
CmR pCX-pL-xylAXBCc pCL-xylCDCc grew on D-xylose at a
rate of 0.20±0.01 h 1, the cells stopped growing after they
reached a dry cell weight (DCW) of only 0.18±0.01 g l 1
(OD600 of 0.59±0.01; Fig. 5b; Table 2). By contrast E. coli
BW25113 Dicd DxylAB :: CmR pCX-pL-xylAXBCc grew on
D-xylose at exactly the same rate, but the final DCW was 1.03
±0.02 g l 1 (OD600 of 3.12±0.01; Fig. S7). Therefore, the pres-
ence of pCL-xylCDCc caused premature cessation of growth,
but had no effect on the growth rate.
We tested the hypothesis that the cessation of growth
might be due to the presence of the additional pCL plas-
mid by comparing the growth of an isogenic strain trans-
formed with the empty pCL vector. E. coli BW25113 Dicd
DxylAB :: CmR pCX-pL-xylAXBCc pCL reached a final
DCW of 1.12±0.05 g l 1 (OD600 of 3.38±0.14), similar to
the progenitor strain, but the growth rate was 25% lower
(0.15±0.01 h 1; Fig. 5a; Table 2). Thus, the presence of the
pCL empty vector only affected the growth rate but not
the biomass yield, and the cessation of growth observed
with E. coli BW25113 Dicd DxylAB :: CmR pCX-pL-
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Fig. 3. Growth in microtitre plates of strains isolated from Weimberg pathway libraries. E. coli BW25113 Dicd DxylAB :: CmR trans-
formed with pCX libraries were selected for growth on D-xylose-containing agar plates, and 12 single colonies were picked and inocu-
lated into Bioscreen microtitre plates containing ML-XKm (360 µl total volume per well). Growth was followed at 37

C with shaking
(red lines). E. coli BW25113 pCX was also analysed as a control (black lines). The figure shows the growth of colonies from libraries 1
to 6 in separate graphs, and the order of the C. crescentus genes (xylACc, xylBCc and xylXCc) in the synthetic operon is indicated.
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xylAXBCc pCL-xylCDCc was due to expression of XylCCc
(encoding XL) and/or xylDCc (encoding XD). Rather than
improving the ability of the strain to use D-xylose via the
Weimberg pathway, the presence of C. crescentus XD and
XL was detrimental. Therefore, further strain optimization
was focused on improving the growth of strains expressing
xylAXBCc, and relying upon spontaneous hydrolysis of
xylonolactone and the native E. coli XD activity to produce
D-KDX.
E. coli BW25113 Dicd DxylAB :: CmR pCX-pL-xylAXBCc
pCL-xylCDCc contained the icd deletion, which had been
introduced to enable rapid strain selection. Isocitrate dehy-
drogenase is required for operation of the complete oxida-
tive TCA cycle, and the Dicd mutants would instead be
reliant on alternative pathways for oxidation of the 2-oxo-
glutarate formed by the Weimberg pathway (e.g. the glyoxy-
late shunt or the succinate oxidation pathway). Such
pathways generate much less energy than the TCA cycle,
which may account for the observed reduction in growth
rate. Therefore, we tested the effect of restoring the native
isocitrate dehydrogenase activity by preparing isogenic
strains lacking the icd deletion.
E. coli BW25113 DxylAB :: CmR pCX-pL-xylAXBCc pCL-
xylCDCc behaved in almost exactly the same way as the Dicd
counterpart, with exactly the same growth rate and with
growth stopping prematurely at a DCW of 0.10±0.01 g l 1
(OD600 of 0.31±0.01; Table 2). Therefore, the growth inhibi-
tion caused by xylCDCc expression cannot be overcome by
restoring a fully functional TCA cycle.
By contrast, E. coli BW25113 DxylAB :: CmR pCX-pL-
xylAXBCc pCL was able to grow 20% faster than the Dicd
counterpart (0.18±0.01 h 1), and reached a final biomass con-
centration that was 48% higher (DCW of 1.66±0.02 g l 1 and
OD600 of 5.04±0.05), so that the growth yield on D-xylose was
60% higher (Fig. 5d; Table 2). The final biomass concentra-
tion was also 57% higher than that of the PPP-dependent
strain, E. coli BW25113 pCX pCL, and the growth yield had
increased by 53.5% (Fig. 5; Table 2), although the growth rate
was still 59% lower (Fig. 5; Table 2) than that for E. coli
BW25113 pCX pCL.
Formation of intermediates and metabolic products
To further characterize the newly developed strains, we also
monitored accumulation of intermediates and fermentation
products during the growth of each of the strains (Table 2;
Fig. 5). E. coli BW25113 pCX pCL showed rapid consump-
tion of D-xylose via the PPP, followed by slower consumption
after growth stopped. There was transient accumulation of
pyruvate, lactate, succinate, formate and 2-oxoglutarate on
the approach to the stationary phase, followed by accumula-
tion of ethanol, formate and acetate. The accumulation of
these fermentation products was likely due to oxygen limita-
tion, which is known to occur in shake flasks [33], and this,
together with the accumulation of these inhibitory organic
acids [34–36], may explain why growth stopped before
D-xylose had been completely consumed.
By contrast, E. coli BW25113 Dicd DxylAB :: CmR pCX-pL-
xylAXBCc pCL, with the xylAXBCc genes and the icd dele-
tion, was able to consume the D-xylose completely, but
D-xylonolactone/D-xylonate began to accumulate after 41 h.
This is consistent with the experiments in vitro, which
had suggested that the formation of D-KDX from
D-xylonolactone/D-xylonate was a rate-limiting step (Fig. 4).
This organism also produced acetate, but to a final concen-
tration that was 47% lower than in the cultures of E. coli
BW25113 pCX pCL, although both strains accumulated
2-oxoglutarate transiently, followed by later reconsumption.
Formate was present in trace amounts, ethanol was not
observed, and the transient accumulation of lactate was
absent. The limited ability to consume D-xylonolactone/D-
xylonate suggests that the growth of E. coli BW25113 Dicd
DxylAB :: CmR pCX-pL-xylAXBCc pCL was limited by
incomplete metabolism of D-xylose, rather than being lim-
ited by the accumulation of inhibitory organic acids.
Interestingly, succinate and pyruvate also accumulated. This
may be due to the icd deletion, which prevents the operation
of the TCA cycle, potentially affecting the metabolism of
these intermediates. Indeed, the isogenic strain with restored
Fig. 4. In vitro effect of addition of C. crescentus XL and XD. Cell-free
extracts of E. coli BL21(DE3) pLysS pET-20b(+)xylBCc, pET-20b(+)xylXCc,
pET-20b(+)xylACc, pET-20b(+)xylCCc and pET-20b(+)xylDCc, expressing
XDH, KdxD, DPDH, XL or XD, were obtained individually, mixed as indi-
cated and assayed for the formation of 2-oxoglutarate from D-xylose
(5mM) in reaction mixtures (1ml in microcentrifuge tubes) containing
100mM Tris-HCl buffer, pH 7.4, MgCl2 (50mM), NAD
+ (10mM) and
NADP+ (10mM) at 37

C, with shaking at 200 r.p.m. The amount of total
protein added from each cell-free extract was 0.1mg. Where indi-
cated, the amount of XD was increased to 0.2mg (XDx2) or 0.3mg
(XDx3). Product concentrations were determined after 6 h. D-KDX could
not be detected in any reactions. Assays were performed in triplicate,
and the means and standard errors are shown.
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isocitrate dehydrogenase activity (E. coli BW25113 DxylAB ::
CmR pCX-pL-xylAXBCc pCL) produced acetate and for-
mate, but no pyruvate; succinate was produced transiently,
but at a much lower concentration compared to that for
E. coli BW25113 Dicd DxylAB :: CmR pCX-pL-xylAXBCc
pCL. Furthermore, D-xylonolactone/D-xylonate accumula-
tion was also transient, and was consumed almost
completely thereafter, alongside consumption of D-xylose.
Once the D-xylose had been fully consumed, slow growth
continued, and the accumulated D-xylonolactone/D-xylo-
nate and succinate continued to be consumed. When growth
stopped, the main detectable metabolic products were
D-xylonolactone/D-xylonate, acetate and formate, at lower
accumulation compared to all of the other strains tested.
This indicates that D-xylose oxidation was more efficient,
and may explain why the strain was able to reach a higher
final biomass and growth yield than E. coli BW25113 Dicd
DxylAB :: CmR pCX-pL-xylAXBCc pCL and E. coli BW25113
pCX pCL (Table 2).
The presence of the xylCDCc genes had a detrimental effect
on D-xylose utilization, whether or not the icd deletion was
present. Thus, E. coli BW25113 Dicd DxylAB :: CmR pCX-
pL-xylAXBCc pCL-xylCDCc and E. coli BW25113 DxylAB ::
CmR pCX-pL-xylAXBCc pCL-xylCDCc behaved identically
with respect to substrate consumption and product forma-
tion (Table 2). These strains were only able to consume
39.8±0.03% of the D-xylose, and accumulation of
D-xylonolactone/D-xylonate was not detected. This confirms
that C. crescentus XL and XD catalyze the efficient conver-
sion of D-xylose to D-KDX both in vitro and in vivo.
Fig. 5. Analysis of growth and metabolic intermediates. Growth and metabolic profile of E. coli BW25113 Dicd DxylAB :: CmR pCX-pL-
xylAXBCc pCL (a), E. coli BW25113 Dicd DxylAB :: Cm
R pCX-pL-xylAXBCc pCL-xylCDCc (b), E. coli BW25113 pCX pCL (c) and E. coli BW25113
DxylAB :: CmR pCX-pL-xylAXBCc pCL (d) when grown on ML-XKm-Cb. The cells were grown in flasks (100ml culture volume) and the dry
cell weight (DCW) and OD600 are indicated. The presence of D-xylose, acetate, lactate, formate, succinate, ethanol, 2-oxoglutarate, pyru-
vate, D-KDX and D-xylonolactone/D-xylonate was analysed at intervals. Assays were performed in triplicate, and the means and stan-
dard errors are shown. The growth rate for each strain (µ) is also indicated.
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However, pyruvate accumulated to higher concentrations
than any other strains, together with modest concentrations
of acetate.
DISCUSSION
The utilization of pentose sugars via carbon-efficient meta-
bolic routes is crucial to underpin future atom economy in the
biomanufacturing of chemicals [1]. The Weimberg pathway
[9] provides an efficient alternative to the classical PPP to con-
vert D-xylose to TCA cycle intermediates, since it minimizes
wasteful loss of carbon in the form of CO2 (Fig. 1). In this
study, we successfully engineered an E. coli strain to use the
Weimberg pathway constitutively by expressing the genes
from C. crescentus, xylAXBCc, from the constitutive pL pro-
moter and deleting the native xylABEc genes. As a result, this
strain was able to grow efficiently on D-xylose without the
Table 2. Summary of growth rate, final biomass and metabolite data. The full values for the metabolite data are available in Table S1
Strain Growth rate (µ 1) Final biomass
Dry cell weight (g l 1) (OD600)
Key metabolite data (g l 1)
E. coli BW25113
pCX pCL
(Fig. 5c)
0.44±0.01 1.06±0.01 (3.22±0.01) Final concentration:
D-xylose (0.86±0.01)
Acetate (4.80±0.04)
Formate (0.65±0.01)
Ethanol (0.29±0.01)
Succinate (0.01±0.01)
2-oxoglutarate (0.01±0.01)
Pyruvate (0.01±0.01)
Lactate (0.01±0.01)
Transient accumulation:
Lactate (1.71±0.03)
Pyruvate (1.23±0.03)
Formate (0.72±0.03)
Succinate (0.08±0.01)
2-oxoglutarate (0.45±0.01)
E. coli BW25113
Dicd DxylAB :: CmR
pCX-pL-xylAXBCc pCL
(Fig. 5a)
0.15±0.01 1.12±0.05 (3.38±0.14) Final concentration:
D-xylonolactone/D-xylonate (2.85±0.16)
Acetate (2.25±0.01)
Succinate (0.61±0.03)
Pyruvate (0.14±0.01)
Formate (0.07±0.01)
2-oxoglutarate (0.06±0.01)
Transient accumulation:
Succinate (0.98±0.07)
2-oxoglutarate (0.11±0.01)
E. coli BW25113
DxylAB :: CmR
pCX-pL-xylAXBCc pCL
(Fig. 5d)
0.18±0.01 1.66±0.02 (5.04±0.05) Final concentration:
Acetate (2.74±0.06)
Formate (0.30±0.01)
D-xylonolactone/D-xylonate (0.21±0.02)
Succinate (0.03±0.01)
Transient accumulation:
Acetate (3.49±0.31)
D-xylonolactone/D-xylonate (2.43±0.71)
Succinate (0.71±0.01)
Lactate (0.20±0.01)
E. coli BW25113
Dicd DxylAB :: CmR
pCX-pL-xylAXBCc pCL-xylCDCc
(Fig. 5b)
0.20±0.01 0.18±0.01 (0.59±0.01) Final concentration:
D-xylose (6.52±0.05)
Pyruvate (0.64±0.02)
Acetate (0.41±0.01)
Succinate (0.23±0.04)
Lactate (0.16±0.04)
2-oxoglutarate (0.11±0.00)
Formate (0.08±0.01)
E. coli BW25113
DxylAB :: CmR
pCX-pL-xylAXBCc pCL-xylCDCc
0.20±0.01 0.10±0.01 (0.31±0.01) Final concentration:
D-xylose (6.86±0.06)
Pyruvate (0.40±0.02)
Acetate (0.44±0.01)
Succinate (0.24±0.02)
Lactate (0.23±0.02)
Formate (0.06±0.03)
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addition of glucose or other nutritional supplements. This
opens the way to low-cost, atom-efficient, simplified biopro-
cesses to manufacture chemicals from waste biomass without
any reliance on food-grade sugars or the need for multiple
substrates and/or multiple feeding strategies during the fer-
mentation. Constitutive expression also paves the way for
future continuous biomanufacturing processes.
E. coli BW25113 DxylAB :: CmR pCX-pL-xylAXBCc pCL was
able to grow efficiently on D-xylose with an improved bio-
mass yield compared with the wild-type host strain growing
on D-xylose using the classical PPP, although the growth
rate was lower. The increased growth yield is surprising
because the PPP operating in the wild-type strain generates
31.7 mole ATP/mole D-xylose, whereas oxidation of
D-xylose via the Weimberg pathway, TCA cycle, malic
enzyme and pyruvate dehydrogenase generates only 30
mole ATP/mole D-xylose (Fig. S4). Therefore, further work
is needed to explain the improved growth efficiency.
We obtained some evidence that the growth rate was com-
promised because of the maintenance of the recombinant
plasmid, but multiple additional factors may also be
involved. For example, it is possible that the metabolic bur-
den of expressing multiple heterologous proteins could have
an effect. Moreover, when we expressed xylAXBCc using an
IPTG-inducible system, a portion of the enzymes was insol-
uble and, for DPDH, we even had to decrease the tempera-
ture after induction to 18

C for better protein yields (Fig.
S5), a strategy that is widely used to improve the solubility
of heterologous proteins [37]. This suggests that the folding
of the enzymes from the Weimberg pathway is not optimal
in E. coli. It is also possible that the growth rate was inhib-
ited by transient accumulation of D-xylonolactone/D-xylo-
nate, which is known to be toxic [31, 32].
We have also considered the possibility that an increased
energy requirement for biosynthesis may have compro-
mised the growth rate. Although a significant proportion of
the biosynthetic requirements can be met through the utili-
zation of 2-oxoglutarate and other TCA cycle intermediates
for amino acid biosynthesis, the cells also need to produce
biosynthetic intermediates from pyruvate, phosphoenol
pyruvate and sugars (e.g. erythrose 4-phosphate and ribose
5-phosphate). In strains using the Weimberg pathway, these
intermediates may need to be produced via gluconeogenesis,
an ATP-dependent pathway, and it is possible that this may
account for the decreased growth rate. However, this
hypothesis does not explain the somewhat dramatic increase
in the biomass yield during utilization of the Weimberg
pathway compared with that for the wild-type strain, which
can derive the same biosynthetic intermediates directly
from the PPP and glycolysis, without any need for gluco-
neogenesis. Therefore, an alternative explanation is needed
for these unusual and somewhat contradictory observations.
E. coli can metabolize D-KDX using aldolases encoded by
yjhH and yagE (Fig. 1). These enzymes form the Dahms
pathway, which converts D-KDX to pyruvate and
glycolaldehyde [29, 38]. Pyruvate can enter the central
metabolism either towards the generation of biosynthetic
intermediates or via the pyruvate dehydrogenase reaction
(thus producing acetyl-CoA). The glycolaldehyde is first
converted to glycolate by the aldehyde dehydrogenase, aldA
[39–41], which can be metabolized via either the glyoxylate
shunt or the glyoxylate degradation pathway, which con-
verts glyoxylate to tartronate semialdehyde, D-glycerate and
then
2-phosphoglycerate [42]. Therefore, the Dahms pathway
would provide intermediates for sugar biosynthesis without
the requirement to produce phosphoenolpyruvate from
TCA cycle intermediates. This, together with the direct sup-
ply of 2-oxoglutarate for energy generation via the Weim-
berg pathway, may explain the improved biomass yield
compared with that for the wild-type cells relying solely on
the PPP. Therefore, further work will be undertaken to con-
firm this hypothesis by measuring the carbon flux between
the Weimberg and Dahms pathways.
In conclusion, to the best of our knowledge, we have devel-
oped the first E. coli strain able to grow constitutively on
D-xylose via the Weimberg pathway as the sole carbon and
energy source. The new strain has considerable potential for
use as a host to produce fuels and chemicals from lignocel-
lulosic sugars through the addition of new pathway modules
to convert TCA cyle intermediates to industrially relevant
targets, including amino acids [43], itaconate [44], succinate
[45] or other di/tricarboxylic acids [21].
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